- Oxycodone Successfully Delivered into the Bloodstream - Data Demonstrates Sustained Release and Increased Blood Levels of Oxycodone MELBOURNE, Australia, May 29 /PRNewswire-FirstCall/ -- Phosphagenics Limited ("Phosphagenics") (ASX: POH; OTCQX: PPGNY) today announced the successful completion of preclinical studies related to its patented TPM/oxycodone transdermal patch system.

Trial Demonstrates Increased Dermal Penetration of TPM/Lidocaine Compared to Topical Anaesthetic Xylocaine(R) MELBOURNE, Australia, Dec.

MELBOURNE, Australia, March 19 /PRNewswire-FirstCall/ -- Phosphagenics Limited today announced that it has received ethics approval to commence treating patients with Type 1 diabetes in a Phase 2 clinical trial using its patented transdermal insulin delivery system, TPM/Insulin.

MELBOURNE, Australia, March 18 /PRNewswire-FirstCall/ -- Phosphagenics Limited ("Phosphagenics") today announced that an independent panel ("the panel") of food safety experts unanimously concluded that Phosphagenics' patented Phospha E(R) is Generally Recognized As Safe (GRAS).

MELBOURNE, Australia, Sept. 17 /PRNewswire-FirstC